These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


277 related items for PubMed ID: 1149031

  • 1. Mode of action of 9-beta-D-arabinofuranosyladenine on the synthesis of DNA, RNA, and protein in vivo and in vitro.
    Müller WE, Rohde HJ, Beyer R, Maidhof A, Lachmann M, Taschner H, Kahn RK.
    Cancer Res; 1975 Aug; 35(8):2160-8. PubMed ID: 1149031
    [Abstract] [Full Text] [Related]

  • 2. Effect of bleomycin on DNA, RNA, protein, chromatin and on cell transformation by oncogenic RNA viruses.
    Müller WE, Zahn RK.
    Prog Biochem Pharmacol; 1976 Aug; 11():28-47. PubMed ID: 63969
    [Abstract] [Full Text] [Related]

  • 3. Action of 9-beta-D-arabinofuranosyl-2-fluoroadenine on RNA metabolism.
    Huang P, Plunkett W.
    Mol Pharmacol; 1991 Apr; 39(4):449-55. PubMed ID: 1708088
    [Abstract] [Full Text] [Related]

  • 4. Comparison of the actions of 9-beta-D-arabinofuranosyl-2-fluoroadenine and 9-beta-D-arabinofuranosyladenine on target enzymes from mouse tumor cells.
    White EL, Shaddix SC, Brockman RW, Bennett LL.
    Cancer Res; 1982 Jun; 42(6):2260-4. PubMed ID: 7042080
    [Abstract] [Full Text] [Related]

  • 5. Enhancement of 9-beta-d-arabinofuranosyladenine cytotoxicity to mouse leukemia L1210 in vitro by 2'-deoxycoformycin.
    Cass CE, Au-Yeung TH.
    Cancer Res; 1976 Apr; 36(4):1486-91. PubMed ID: 944095
    [Abstract] [Full Text] [Related]

  • 6. Effects of 2-chloro-9-(2-deoxy-2-fluoro-beta-D-arabinofuranosyl)adenine on K562 cellular metabolism and the inhibition of human ribonucleotide reductase and DNA polymerases by its 5'-triphosphate.
    Parker WB, Shaddix SC, Chang CH, White EL, Rose LM, Brockman RW, Shortnacy AT, Montgomery JA, Secrist JA, Bennett LL.
    Cancer Res; 1991 May 01; 51(9):2386-94. PubMed ID: 1707752
    [Abstract] [Full Text] [Related]

  • 7. Inhibition of DNA synthesis by 1-beta-D-arabinofuranosylcytosine.
    Bremerskov V.
    Biomedicine; 1975 May 01; 22(3):217-22. PubMed ID: 1174630
    [Abstract] [Full Text] [Related]

  • 8. Inhibition of nuclear envelope nucleoside triphosphatase-regulated nucleocytoplasmic messenger RNA translocation by 9-beta-D-arabinofuranosyladenine 5'-triphosphate in rodent cells.
    Schröder HC, Nitzgen DE, Bernd A, Kurelec B, Zahn RK, Gramzow M, Müller WE.
    Cancer Res; 1984 Sep 01; 44(9):3812-9. PubMed ID: 6204747
    [Abstract] [Full Text] [Related]

  • 9. Effect of 9-beta-D-arabinofuranosyladenine on DNA synthesis in vivo.
    Müller WE, Maidhof A, Zahn RK, Shannon WM.
    Cancer Res; 1977 Jul 01; 37(7 Pt 1):2282-90. PubMed ID: 301056
    [No Abstract] [Full Text] [Related]

  • 10. Interaction of 9-beta-D-arabinofuranosyladenine, 9-beta-D-arabinofuranosyladenine 5'-monophosphate, and 9-beta-D-arabinofuranosyladenine 5'-triphosphate with S-adenosylhomocysteinase.
    Helland S, Ueland PM.
    Cancer Res; 1981 Feb 01; 41(2):673-8. PubMed ID: 6160909
    [Abstract] [Full Text] [Related]

  • 11. Resistance to 9-beta-D-arabinofuranosyladenine in murine tumor cells.
    LePage GA.
    Cancer Res; 1978 Aug 01; 38(8):2314-6. PubMed ID: 580902
    [Abstract] [Full Text] [Related]

  • 12. Evidence for double replication of chromosomal DNA segments as a general consequence of DNA replication inhibition.
    Woodcock DM, Cooper IA.
    Cancer Res; 1981 Jun 01; 41(6):2483-90. PubMed ID: 7237443
    [Abstract] [Full Text] [Related]

  • 13. Inhibitory effects of 9-beta-D-arabinofuranosylguanine 5'-triphosphate and 9-beta-D-arabinofuranosyladenine 5'-triphosphate on DNA polymerases from murine cells and oncornavirus.
    Ono K, Ohashi A, Yamamoto A, Matsukage A, Takahasi T, Saneyoshi M, Ueda T.
    Cancer Res; 1979 Nov 01; 39(11):4673-80. PubMed ID: 91427
    [Abstract] [Full Text] [Related]

  • 14. Effect of adriamycin on DNA, RNA, and protein synthesis in cell-free systems and intact cells.
    Momparler RL, Karon M, Siegel SE, Avila F.
    Cancer Res; 1976 Aug 01; 36(8):2891-5. PubMed ID: 1277199
    [Abstract] [Full Text] [Related]

  • 15. Two approaches that increase the activity of analogs of adenine nucleosides in animal cells.
    Plunkett W, Cohen SS.
    Cancer Res; 1975 Jun 01; 35(6):1547-54. PubMed ID: 1079475
    [Abstract] [Full Text] [Related]

  • 16. Enhancement of the antitumor activity of arabinofuranosyladenine of 2'-deoxycoformycin.
    LePage GA, Worth LS, Kimball AP.
    Cancer Res; 1976 Apr 01; 36(4):1481-5. PubMed ID: 946595
    [Abstract] [Full Text] [Related]

  • 17. Resistance to 9-beta-D-arabinofuranosyladenine in cultured leukemia L 1210 cells.
    Cass CE, Selner M, Phillips JR.
    Cancer Res; 1983 Oct 01; 43(10):4791-8. PubMed ID: 6603904
    [Abstract] [Full Text] [Related]

  • 18. Antiproliferative effects of 9-beta-d-arabinofuranosyladenine in a mammalian cell line devoid of adenosine deaminase activity.
    Drach JC, Sandberg JN, Shipman C.
    J Dent Res; 1977 Mar 01; 56(3):275-88. PubMed ID: 192768
    [Abstract] [Full Text] [Related]

  • 19. Inhibition of primer RNA formation in CCRF-CEM leukemia cells by fludarabine triphosphate.
    Catapano CV, Chandler KB, Fernandes DJ.
    Cancer Res; 1991 Apr 01; 51(7):1829-35. PubMed ID: 1706219
    [Abstract] [Full Text] [Related]

  • 20. Incorporation of 1-beta-D-arabinofuranosylcytosine into DNA from herpes simplex virus resistant to 9-beta-D-arabinofuranosyladenine.
    Kufe D, Herrick D, Crumpacker C, Schnipper L.
    Cancer Res; 1984 Jan 01; 44(1):69-73. PubMed ID: 6317173
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 14.